Clinical Trial Update: Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating user preference, satisfaction, and ease of use of the Genuair inhaler (Pressair) and the Breezhaler inhaler (Neohaler) in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Breezhaler
• Genuair

Snippet

Sponsor: Almirall, S.A. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED